左旋多巴（L-3,4-二羟基苯丙氨酸）——其在帕金森病中的临床疗效。 - Suppr

Suppr

超能文献

L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism.

作者信息

Yahr M D, Duvoisin R C, Hoehn M M, Schear M J, Barrett R E

出版信息

Trans Am Neurol Assoc. 1968;93:56-63.

PMID:4885744

Abstract

摘要

相似文献

L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism.左旋多巴（L-3,4-二羟基苯丙氨酸）——其在帕金森病中的临床疗效。

Trans Am Neurol Assoc. 1968;93:56-63.

[Effects of L-dopa and stereotaxic surgery in Parkinsonism].

No To Shinkei. 1970 Sep;22(9):1103-8.

[Use of L-DOPA in the therapy of parkinsonism].

Rass Int Clin Ter. 1971 Feb 28;51(4):193-221.

[Treatment of Parkinsonism with L-dopa--with special reference to clinical effects, side effects and urinary metabolites of catecholamines].左旋多巴治疗帕金森病——特别提及临床疗效、副作用及儿茶酚胺的尿代谢产物

No To Shinkei. 1970 Sep;22(9):1091-101.

Metabolism and clinical assessment of L-dopa in parkinsonism.帕金森病中左旋多巴的代谢与临床评估

Neurology. 1970 Apr;20(4):402.

[Evaluation of L-DOPA in Parkinsonism with special reference to the study by double-blind method].[左旋多巴治疗帕金森病的评估，特别参考双盲法研究]

Naika. 1972;29(2):335-43.

L-dopa and amantadine in the therapy of parkinsonism.

Wis Med J. 1969 Nov;68(11):325-8.

[Clinical experience with L-DOPA in the treatment of parkinsonism].

No To Shinkei. 1970 Dec;22(12):1399-405.

[Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method].

Shinkei Kenkyu No Shimpo. 1971;15(1):267-85.

[Clinical effect of L-DOPA and electromyographic study of Parkinsonism].

No To Shinkei. 1971 Mar;23(3):325-32.

引用本文的文献

Levodopa-Induced Dyskinesia in Parkinson's Disease: Pathogenesis and Emerging Treatment Strategies.左旋多巴诱导的帕金森病运动障碍：发病机制与新兴治疗策略。

Cells. 2022 Nov 23;11(23):3736. doi: 10.3390/cells11233736.

Stem Cell-Derived Exosomes: a New Strategy of Neurodegenerative Disease Treatment.干细胞衍生的外泌体：一种治疗神经退行性疾病的新策略。

Mol Neurobiol. 2021 Jul;58(7):3494-3514. doi: 10.1007/s12035-021-02324-x. Epub 2021 Mar 21.

Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.利用体内18F-9-氟丙基-(+)-二氢丁苯那嗪PET成像对厚朴酚治疗MPTP诱导的帕金森病小鼠模型的疗效进行定量分析。

PLoS One. 2017 Mar 3;12(3):e0173503. doi: 10.1371/journal.pone.0173503. eCollection 2017.

Basal Ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia.基底神经节回路在左旋多巴诱导的运动障碍的病理生理学中的作用。

Front Neuroanat. 2010 Sep 14;4. doi: 10.3389/fnana.2010.00131. eCollection 2010.

Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.静脉注射间充质干细胞对帕金森病大鼠模型具有治疗作用：重点关注基质细胞衍生因子-1α的神经保护作用。

BMC Neurosci. 2010 Apr 26;11:52. doi: 10.1186/1471-2202-11-52.

Four decades of neurodegenerative disease research: how far we have come!四十年的神经退行性疾病研究：我们已经取得了多大的进展！

J Neurosci. 2009 Oct 14;29(41):12722-8. doi: 10.1523/JNEUROSCI.3767-09.2009.

Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesia.感觉运动、边缘系统和联合基底神经节区域在左旋多巴诱导的异动症中的作用。

J Neurosci. 2005 Feb 23;25(8):2102-7. doi: 10.1523/JNEUROSCI.5059-04.2005.

Laevo-dopa for Parkinsonism.左旋多巴治疗帕金森病。

Br Med J. 1970 Feb 21;1(5694):446-7.

Miosis during L-dopa therapy.左旋多巴治疗期间的瞳孔缩小。

Br Med J. 1970 Jun 13;2(5710):639-40. doi: 10.1136/bmj.2.5710.639.

The cerebrospinal fluid homovanillic acid concentration in patients with Parkinsonism treated with L-dopa.接受左旋多巴治疗的帕金森病患者脑脊液中高香草酸的浓度。

J Neurol Neurosurg Psychiatry. 1970 Feb;33(1):1-6. doi: 10.1136/jnnp.33.1.1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验